论文部分内容阅读
脂肪肝的治疗在目前尚缺乏特效疗法,为进一步提高脂肪肝的治疗水平,我们将1994年10月～1997年12月收治的60例脂肪肝患者随机分为治疗组和对照组,经临床观察,认为胞二磷胆碱治疗脂肪肝效果较好。现总结如下。 1 资料与方法 1.1 病例选择:60例病例均系住院患者。年龄28～60岁,平均45.4±14.5岁;病程0.5～10年,大多数为1～2年。治疗组30例,其中男22例,女8例。30例中,非酒精性脂肪肝24例(肥胖性脂肪肝12例,糖尿病性脂肪肝8例,高脂血症性脂肪肝4例),酒
In order to further improve the therapeutic level of fatty liver, 60 patients with fatty liver treated from October 1994 to December 1997 were randomly divided into treatment group and control group. The clinical observation , That citicoline treatment of fatty liver better. Now summarized as follows. 1 Materials and Methods 1.1 Case Selection: 60 cases were hospitalized patients. The age of 28 to 60 years, mean 45.4 ± 14.5 years; duration of 0.5 to 10 years, most of 1 to 2 years. Treatment group of 30 patients, including 22 males and 8 females. In the 30 cases, 24 cases of non-alcoholic fatty liver (12 cases of obesity fatty liver, 8 cases of diabetic fatty liver and 4 cases of hyperlipidemic fatty liver)